New Low-Testosterone Warnings from the FDA?
Due to some new concerns about testosterone treatments, the US Food and Drug Administration (FDA) is meeting to discuss if further warnings need to be added to low-testosterone treatment medications. The FDA has already added warnings to testosterone replacement drugs because they can cause blood clots.
The warnings had to be updated after loads of lawsuits were filed. The original warnings claimed that blood clots could only form if a person already had an abnormally high red blood cell count. However, the lawsuits proved that people were getting blood clots that had normal red blood cell counts.
This new meeting is to determine if testosterone-replacement therapy can have adverse effects on the cardiovascular system regardless of the person's pre-existing medical history. The FDA also plans on determining the appropriate persons that should take testosterone-replacement medications.
Health Canada joined the discussion encouraging further investigation saying that their investigations have found that serious life-threatening conditions can arise from testosterone-replacement therapies.
If you or a loved one has suffered from taking testosterone-replacement drugs, please contact Kalfus & Nachman. Our experienced Norfolk defective product lawyers can help you get the settlement you deserve. We serve clients in all of Virginia and Northest North Carolina. Call us today at (855) 880-8163.